Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cardio Diagnostics Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cardio Diagnostics Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Fung Peter K | Director | – | Jul 2, 2026 | 4 |
| Betts Wendy J | Director | – | Jul 2, 2026 | 4 |
| Intrater James | Director | 71,596 | Jul 2, 2026 | 4 |
| Burton Paul Frederick | Director | 8,803 | Jul 2, 2026 | 4 |
| Levy Oded | Director | 71,596 | Oct 10, 2024 | 0 |
| Lau Stanley K. | Director | 100,325 | Oct 10, 2024 | 0 |
| Dogan Timur | Chief Technology Officer | 197,310 | Oct 9, 2024 | 0 |
| Dogan Meeshanthini | Chief Executive Officer | 1,655,429 | Oct 8, 2024 | 0 |
| Philibert Robert | Chief Medical Officer | 1,683,867Indirect | Sep 10, 2024 | 0 |
| Hosseinion Warren | Director | – | Feb 21, 2024 | 0 |
| Luqman Elisa V | Chief Financial Officer | – | Feb 21, 2024 | 0 |
| Abdullahi Khullani | VP of Revenue and Strategy | – | Feb 21, 2024 | 0 |
| Sim Brandon | Director | 62,793 | Jan 2, 2024 | 0 |
| Mana Capital LLC | 10% Owner | 0 | Oct 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2024 (view filing)1:18 PM ET | Sep 6 | 33 days | Dogan TimurChief Technology Officer | PPurchase | +69.0K | $0.29 | +$20.0K | +53.7%197.3K after | Amended |
| Oct 8, 2024 (view filing)10:42 AM ET | Sep 6 | 32 days | Dogan MeeshanthiniChief Executive Officer | PPurchase | +69.0K | $0.29 | +$20.0K | +4.3%1.66M after | Amended |
| Sep 10, 2024 (view filing)5:22 PM ET | Sep 6 | 4 days | Philibert RobertChief Medical Officer | PPurchase | +34.1K | $0.2865 | +$9.76K | +2.1%1.68M after | 2 lots |
| Sep 9, 2024 (view filing)11:08 AM ET | Sep 6 | 3 days | Dogan MeeshanthiniChief Technology Officer | PPurchase | +69.0K | $0.29 | +$20.0K | +53.7%197.3K after | |
| Sep 9, 2024 (view filing)11:01 AM ET | Sep 6 | 3 days | Dogan MeeshanthiniChief Executive Officer | PPurchase | +69.0K | $0.29 | +$20.0K | +4.3%1.68M after | |
| Oct 4, 2023 (view filing)11:39 AM ET | Sep 30 | 4 days | Levy OdedDirector | PPurchaseRestricted Stock Units | – | – | – | – | AmendedDerivative |
| Oct 4, 2023 (view filing)11:34 AM ET | Sep 30 | 4 days | Intrater JamesDirector | PPurchaseRestricted Stock Units | – | – | – | – | AmendedDerivative |
| Sep 8, 2023 (view filing) | Aug 25-31 | 14 daysLate | Dogan MeeshanthiniChief Executive Officer | PPurchase | +18.3K | $0.551 | +$10.1K | +16.6%128.3K after | 2 lotsDuplicate filing |
| Sep 8, 2023 (view filing) | Aug 25-31 | 14 daysLate | Dogan TimurChief Technology Officer | PPurchase | +18.3K | $0.551 | +$10.1K | +16.6%128.3K after | 2 lots |
| Sep 5, 2023 (view filing) | Aug 24-28 | 12 daysLate | Philibert RobertChief Medical Officer | PPurchase | +34.0K | $0.5999 | +$20.4K | +2.1%1.65M after | 3 lots |